Your browser doesn't support javascript.
loading
Regional Citrate Anticoagulation Protocol for Patients with Presumed Absent Citrate Metabolism.
Szamosfalvi, Balazs; Puri, Vidhit; Sohaney, Ryann; Wagner, Benjamin; Riddle, Amy; Dickinson, Sharon; Napolitano, Lena; Heung, Michael; Humes, David; Yessayan, Lenar.
Afiliação
  • Szamosfalvi B; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Puri V; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Sohaney R; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Wagner B; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Riddle A; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Dickinson S; Division of Acute Care Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
  • Napolitano L; Division of Acute Care Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
  • Heung M; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Humes D; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Yessayan L; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
Kidney360 ; 2(2): 192-204, 2021 02 25.
Article em En | MEDLINE | ID: mdl-35373034
Background: Regional citrate anticoagulation (RCA) is not recommended in patients with shock or severe liver failure. We designed a protocol with personalized precalculated flow settings for patients with absent citrate metabolism that abrogates risk of citrate toxicity, and maintains neutral continuous KRT (CKRT) circuit calcium mass balance and normal systemic ionized calcium levels. Methods: A single-center prospective cohort study of patients in five adult intensive care units triaged to the CVVHDF-RCA "Shock" protocol. Results: Of 31 patients included in the study, 30 (97%) had AKI, 16 (52%) had acute liver failure, and five (16%) had cirrhosis at the start of CKRT. The median lactate was 5 mmol/L (interquartile range [IQR], 3.2-10.7), AST 822 U/L (IQR, 122-2950), ALT 352 U/L (IQR, 41-2238), total bilirubin 2.7 mg/dl (IQR, 1.0-5.1), and INR two (IQR, 1.5-2.6). The median first hemofilter life censored for causes other than clotting exceeded 70 hours. The cumulative incidence of hypernatremia (Na >148 mM), metabolic alkalosis (HCO3- >30 mM), and hypophosphatemia (P<2 mg/dl) were one out of 26 (4%), zero out of 30 (0%), and one out of 30 (3%), respectively, and were not clinically significant. Mild hypocalcemia occurred in the first 4 hours in two out of 31 patients, and corrected by hour 6 with no additional Ca supplementation beyond the per-protocol administered Ca infusion. The maximum systemic total Ca (tCa; mM)/ionized Ca (iCa; mM) ratio never exceeded 2.5. Conclusions: The Shock protocol can be used without contraindications and is effective in maintaining circuit patency with a high, fixed ACDA infusion rate to blood flow ratio. Keeping single-pass citrate extraction on the dialyzer >0.75 minimizes the risk of citrate toxicity even in patients with absent citrate metabolism. Precalculated, personalized dosing of the initial Ca-infusion rate from a table on the basis of the patient's albumin level and the filter effluent flow rate maintains neutral CKRT circuit calcium mass balance and a normal systemic iCa level.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Cítrico / Anticoagulantes Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Cítrico / Anticoagulantes Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article